CM
LKFT

Castleark Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Castleark Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,340
Closed -$462K – 358
2020
Q2 		$462K Hold
2,340
– – 0.02% 263
2020
Q1 		$458K Sell
2,340
-740
-24% -$159K 0.03% 234
2019
Q4 		$637K Hold
3,080
– – 0.03% 265
2019
Q3 		$470K Sell
3,080
-5,570
-64% -$913K 0.02% 293
2019
Q2 		$1.11M Buy
8,650
+370
+4% +$43.9K 0.04% 241
2019
Q1 		$975K Hold
8,280
– – 0.04% 263
2018
Q4 		$760K Sell
8,280
-4,480
-35% -$454K 0.03% 275
2018
Q3 		$1.44M Buy
12,760
+2,890
+29% +$305K 0.04% 273
2018
Q2 		$910K Buy
9,870
+3,166
+47% +$307K 0.03% 283
2018
Q1 		$669K Sell
6,704
-66
-1% -$7.11K 0.02% 295
2017
Q4 		$635K Sell
6,770
-3,105
-31% -$294K 0.02% 308
2017
Q3 		$1M Buy
9,875
+3,800
+63% +$332K 0.03% 282
2017
Q2 		$465K Hold
6,075
– – 0.02% 316
2017
Q1 		$524K Sell
6,075
-1,815
-23% -$131K 0.02% 311
2016
Q4 		$506K Buy
7,890
+4,560
+137% +$281K 0.02% 313
2016
Q3 		$215K Sell
3,330
-370
-10% -$20.9K 0.01% 327
2016
Q2 		$205K Hold
3,700
– – 0.01% 323
2016
Q1 		$155K Buy
3,700
+700
+23% +$32.5K ﹤0.01% 334
2015
Q4 		$189K Buy
+3,000
New +$153K 0.01% 339

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Castleark Management's LKFT Position: Q3 2020 in Review

Castleark Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 2,340 shares — an estimated $462K sold.

Castleark Management first reported a position in LKFT in Q4 2015 and held it in 19 quarters. The position peaked at $1.44M in Q3 2018. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

  • Castleark Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Castleark Management sold 2,340 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $462K.
  • Castleark Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and held it in 19 quarters.
  • Castleark Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.44M in Q3 2018.
  • 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Castleark Management's 13F filing for Q3 2020, filed 16 Nov 2020.